APP and Alzheimer disease: Some of the serotonin modulators induce changes in the expression or processing of APP, therefore affecting the amyloidogenic pathway [106]; moreover, serotonin transporter (SERT) expression is decreased in patients with AD, thus appearing a reliable neural marker associated with memory mechanisms [104].